ArticlePharmaceutics2024

Development of a Formulation and In Vitro Evaluation of a Pulmonary Drug Delivery System for a Novel Janus Kinase (JAK) Inhibitor, CPL409116.

Aleksandra Rzewińska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.